Clinical Trials at Chase Medical Research, LLC
As of September 2026, 7 paid clinical trials are recruiting at Chase Medical Research, LLC in Waterbury, Connecticut. Active studies at this site cover conditions such as Obesity, Overweight and Breast Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
7 clinical trials at Chase Medical Research, LLC
·Clear filters·A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Common conditions studied in Waterbury
- Obesity (6 active studies)
- Overweight (6 active studies)
- Breast Cancer (5 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies)
- Stage IV Lung Cancer AJCC v8 (4 active studies)
- Recurrent Lung Non-Small Cell Carcinoma (3 active studies)
Leading research sponsors in Waterbury
- SWOG Cancer Research Network
- National Cancer Institute (NCI)
- NRG Oncology
- ECOG-ACRIN Cancer Research Group
- Eli Lilly and Company
Frequently asked questions
How many paid clinical trials are currently recruiting in Waterbury?
There are approximately 66 recruiting clinical trials in Waterbury, Connecticut listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Waterbury pay participants?
Most recruiting trials in Waterbury compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Waterbury?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Waterbury?
The most common conditions under active study in Waterbury include Obesity (6), Overweight (6), Breast Cancer (5), Anatomic Stage II Breast Cancer AJCC v8 (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Waterbury?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Waterbury on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Waterbury?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Waterbury?
Recruiting research sites in Waterbury include Smilow Cancer Hospital-Waterbury Care Center, Chase Medical Research, LLC, Chase Medical Research LLC, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Waterbury right now?
The largest active categories in Waterbury are Cancer & tumors (41), Diabetes & metabolic (7), Neurology & pain (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.